School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Merck & Co Inc MRK

Healthcare · Pharmaceuticals

$145.60last close 2026-10-09 · market cap $359.22B · delayed data

Trailing returns

1M-0.73%
3M+17.10%
6M+20.24%
1Y+71.29%
5Y+110.42%

Basis: Adjusted daily closes.

What it does

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes.

Open MRK in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies